LY4065967

DRUG5 trials

Sponsors

Eli Lilly and Company

Conditions

Chronic PainDiabetic Peripheral Neuropathic PainHealthyLow Back PainOsteoarthritis, Knee

Phase 1

A Study of LY4065967 in Healthy Japanese Participants

CompletedNCT06594159

Eli Lilly and CompanyHealthy

Start: 2024-10-22End: 2025-03-11Updated: 2025-04-03

A Study of [14C]-LY4065967 in Healthy Participants

CompletedNCT07039045

Eli Lilly and CompanyHealthy

Start: 2025-06-23End: 2025-08-16Updated: 2025-09-09

Phase 2

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

RecruitingNCT07285018

Eli Lilly and CompanyDiabetic Peripheral Neuropathic Pain

Start: 2026-02-16End: 2027-07-01Target: 150Updated: 2026-07-07

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain

RecruitingNCT07641504

Eli Lilly and CompanyChronic Pain, Low Back Pain

Start: 2026-08-12End: 2027-04-01Target: 150Updated: 2026-09-04

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

RecruitingNCT07641517

Eli Lilly and CompanyChronic Pain, Osteoarthritis, Knee

Start: 2026-06-25End: 2027-04-01Target: 150Updated: 2026-09-04